Imexpharm Corporation

Imexpharm Corporation company information, Employees & Contact Information

Established in 1977 in Dong Thap Province, Vietnam, Imexpharm is committed to delivering high-quality healthcare solutions through EU-GMP-standard products recognized for their safety, efficacy, and quality. With nearly five decades of continuous growth, Imexpharm has established a solid foundation in research and development, cutting-edge technology, modern infrastructure, and sustainable practices, all driven by its vision “Trusted quality, European standard”. Today, Imexpharm is the No.1 producer of antibiotics in Vietnam and operates the most EU-GMP-certified production lines in the country, with three EU-GMP factory clusters and 12 EU-GMP certified lines. The company has also obtained 28 European MAUs for 11 products, affirming its global competitiveness. In 2024, Imexpharm successfully completed its bonus share issuance, making it the largest listed pharmaceutical company in Vietnam by charter capital. Imexpharm is a trusted contract manufacturing partner for global pharmaceutical leaders such as Sandoz, Sanofi-Aventis, Agimexpharm, Genuone Sciences Inc., and SK. The company is actively expanding into high-value, high-tech segments and advanced dosage forms, including injectables and dispersible tablets, to enhance healthcare accessibility in Vietnam and accelerate export growth across new markets. Guided by the philosophy ‘1,000 years later, the lotus still blooms,’ Imexpharm, under strong leadership and with a team of over 1,400 dedicated professionals, remains steadfast in its pursuit of sustainable growth and long-term profitability, actively contributing to Vietnam’s vision of becoming a regional hub for high-value pharmaceutical manufacturing by 2030.

Company Details

Employees
220
Founded
-
Address
Cao Lanh, Dong Thap
Phone
+84 277 3851 941
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Cao Lanh, Dong Thap
Looking for a particular Imexpharm Corporation employee's phone or email?

Imexpharm Corporation Questions

News

SK Group in advanced talks with investors for Imexpharm stake sale—sources - ION Analytics

SK Group in advanced talks with investors for Imexpharm stake sale—sources ION Analytics

Vietnam's pharma major Imexpharm sees profit surge on OTC sales recovery - Theinvestor

Vietnam's pharma major Imexpharm sees profit surge on OTC sales recovery Theinvestor

Imexpharm’s gross revenue reaches VND 2,118 billion in first nine months - DTiNews

Imexpharm’s gross revenue reaches VND 2,118 billion in first nine months DTiNews

China's Livzon buys 65% in Vietnam's Imexpharm for over $219m - DealStreetAsia

China's Livzon buys 65% in Vietnam's Imexpharm for over $219m DealStreetAsia

SK Group Is Said to Explore Selling Majority Stake in Vietnam’s Imexpharm - Bloomberg

SK Group Is Said to Explore Selling Majority Stake in Vietnam’s Imexpharm Bloomberg

Imexpharm reports record profit in Q2 - vietnamnews.vn

Imexpharm reports record profit in Q2 vietnamnews.vn

Imexpharm's net revenue rises 22% in first half of 2025 - VnExpress International

Imexpharm's net revenue rises 22% in first half of 2025 VnExpress International

Chinese firm Livzon spends over $219 mln to acquire 64.8% stake in Vietnam's Imexpharm - Theinvestor

Chinese firm Livzon spends over $219 mln to acquire 64.8% stake in Vietnam's Imexpharm Theinvestor

Imexpharm sets growth milestone with high-tech drug strategy - Báo VietNamNet

Imexpharm sets growth milestone with high-tech drug strategy Báo VietNamNet

Chinese pharma giant moves to acquire majority stake in Vietnam’s Imexpharm - Tuoi Tre News | The News Gateway to Vietnam

Chinese pharma giant moves to acquire majority stake in Vietnam’s Imexpharm Tuoi Tre News | The News Gateway to Vietnam

Imexpharm and the breakthrough of domestic pharmaceuticals in 2025 - Vietnam Economic Times

Imexpharm and the breakthrough of domestic pharmaceuticals in 2025 Vietnam Economic Times

Imexpharm’s ambitions to enter global pharma supply chain - Vietnam Investment Review - VIR

Imexpharm’s ambitions to enter global pharma supply chain Vietnam Investment Review - VIR

Vietnam's pharma major Imexpharm to build $58 mln plant in southern Vietnam - Theinvestor

Vietnam's pharma major Imexpharm to build $58 mln plant in southern Vietnam Theinvestor

China’s Livzon Pharma to Gain Control of Vietnamese Peer IMP for USD221 Million - 一财全球Yicai Global

China’s Livzon Pharma to Gain Control of Vietnamese Peer IMP for USD221 Million 一财全球Yicai Global

SK Group Divests Vingroup, Imexpharm: Allens Advises - Mirage News

SK Group Divests Vingroup, Imexpharm: Allens Advises Mirage News

Imexpharm reports nearly $23M in net revenue for Q1 2025 - VnExpress International

Imexpharm reports nearly $23M in net revenue for Q1 2025 VnExpress International

SK may adjust ownership at Vietnam-based pharmacy major Imexpharm - Theinvestor

SK may adjust ownership at Vietnam-based pharmacy major Imexpharm Theinvestor

Vietnam pharma major Imexpharm plans new facilities with proactive investment approach: exec - Theinvestor

Vietnam pharma major Imexpharm plans new facilities with proactive investment approach: exec Theinvestor

Leading pharma firm Imexpharm stock consecutively sets record price highs - Theinvestor

Leading pharma firm Imexpharm stock consecutively sets record price highs Theinvestor

Korean group to hold 65% stake in leading Vietnamese pharma firm Imexpharm - Theinvestor

Korean group to hold 65% stake in leading Vietnamese pharma firm Imexpharm Theinvestor

SK Investment Vina III to hold 65 per cent of Imexpharm - Vietnam Investment Review - VIR

SK Investment Vina III to hold 65 per cent of Imexpharm Vietnam Investment Review - VIR

Vietnam accelerates in high-tech pharmaceutical race - Vietnam Investment Review - VIR

Vietnam accelerates in high-tech pharmaceutical race Vietnam Investment Review - VIR

Pharmaceutical industry sees slowing growth momentum - vietnamnews.vn

Pharmaceutical industry sees slowing growth momentum vietnamnews.vn

Vietnam's pharmaceutical market sees major M&A deal - Vietnam+ (VietnamPlus)

Vietnam's pharmaceutical market sees major M&A deal Vietnam+ (VietnamPlus)

Imexpharm boosts growth with enhanced R&D for global supply chain - Báo VietNamNet

Imexpharm boosts growth with enhanced R&D for global supply chain Báo VietNamNet

International investors scoop up major stakes in drugmakers - Vietnam Investment Review - VIR

International investors scoop up major stakes in drugmakers Vietnam Investment Review - VIR

Imexpharm - Poised to lead growth in pharmaceutical industry - Vietnam Economic Times

Imexpharm - Poised to lead growth in pharmaceutical industry Vietnam Economic Times

Healthcare M&As surge in Vietnam on foreign capital inflows - Theinvestor

Healthcare M&As surge in Vietnam on foreign capital inflows Theinvestor

Vietnamese pharmaceutical market forecasted to grow to $20B by 2045 - VnExpress International

Vietnamese pharmaceutical market forecasted to grow to $20B by 2045 VnExpress International

Foreign investors acquire strategic stakes in Vietnam pharmaceutical firms - Theinvestor

Foreign investors acquire strategic stakes in Vietnam pharmaceutical firms Theinvestor

Vietnamese pharmaceutical enterprises strengthen competitiveness amid international integration - vietnamnews.vn

Vietnamese pharmaceutical enterprises strengthen competitiveness amid international integration vietnamnews.vn

Korean giant SK mulls Southeast Asia asset sale for reinvestment - Theinvestor

Korean giant SK mulls Southeast Asia asset sale for reinvestment Theinvestor

SK invests in two Vietnamese pharmaceutical firms - vietnamnews.vn

SK invests in two Vietnamese pharmaceutical firms vietnamnews.vn

Vietnamese pharma players boost products with high-quality medications - Vietnam Economic Times

Vietnamese pharma players boost products with high-quality medications Vietnam Economic Times

Imexpharm named top 1 'Best Place to Work' in healthcare sector in Vietnam in 2024 - MSN

Imexpharm named top 1 'Best Place to Work' in healthcare sector in Vietnam in 2024 MSN

Imexpharm contributes to Da Lat's greening initiative - MSN

Imexpharm contributes to Da Lat's greening initiative MSN

Top Imexpharm Corporation Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant